The Biostatistics and Bioinformatics Core for the University of Texas M. D. Anderson Cancer Center (UTMDACC) Melanoma SPORE will serve multiple needs for the planning and conduct of the SPORE's translational reseal-ch. Based on a strong track record for providing biostatistical support for translational research, the Core will be,a comprehensive, muiti^lateral respurce for designing clinical and basic science experiments, performing statistical analyses, developing innovative statistical methodology, and publishing the research results generated from this Melanoma SPORE. For this proposed competitive renewal, we plan to continue and to expand the role of the Core in supporting the UTMDACC Melanoma SPORE. We will incorporate sound experimental design principles within each project that will increase the clarity,and enhance interpretability of study results. Each project will be provided with tailored analyses, accompanied by novel statistical development as necessary;to reveal apparent and hidden relationships among data.. The Core will collaborate with all project investigators to facilitate the timely publication of Melanoma SPORE research. The main objectives of the Biostatistics and Bioinformatics Core are: 1. To provide guidance for the statistical design and sample size and power calculations for each project. 2. To provide all statistical data analysis including descriptive statistical analysis, hypothesis testing, estimation, and modeling bf prospectively generated data., 3. To ascertain that conclusions drawn, from a|l projects are based on well-designed experiments and appropriate interpretation of results. 4. To develop and adapt innovative statistical methods pertinent to translational melanoma studies. 5. To generate statistical reports for all projects. 6. To collaborate and assist all project investigators in the publication of scientific results.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center (P50)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-M)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas MD Anderson Cancer Center
United States
Zip Code
Shi, Qiong; Liu, Hongliang; Han, Peng et al. (2017) Genetic Variants in WNT2B and BTRC Predict Melanoma Survival. J Invest Dermatol 137:1749-1756
Van Roosbroeck, Katrien; Fanini, Francesca; Setoyama, Tetsuro et al. (2017) Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res 23:2891-2904
Kim, Dae Won; Haydu, Lauren E; Joon, Aron Y et al. (2017) Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients. Cancer 123:1372-1381
Fang, Shenying; Vaysse, Amaury; Brossard, Myriam et al. (2017) Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. J Invest Dermatol 137:253-257
Rodriguez-Aguayo, Cristian; Monroig, Paloma Del C; Redis, Roxana S et al. (2017) Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer. Cell Discov 3:17029
Mbofung, Rina M; McKenzie, Jodi A; Malu, Shruti et al. (2017) HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes. Nat Commun 8:451
Reuben, Alexandre; Spencer, Christine N; Prieto, Peter A et al. (2017) Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma. NPJ Genom Med 2:
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Li, Hong; Wang, Yanru; Liu, Hongliang et al. (2017) Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival. Oncotarget 8:74595-74606
Eskiocak, Banu; McMillan, Elizabeth A; Mendiratta, Saurabh et al. (2017) Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov 7:832-851

Showing the most recent 10 out of 271 publications